Equities
Health CareMedical Equipment and Services
  • Price (HKD)2.58
  • Today's Change0.01 / 0.39%
  • Shares traded3.84m
  • 1 Year change-70.34%
  • Beta1.1155
Data delayed at least 15 minutes, as of Jul 26 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Peijia Medical Ltd is a China-based holding company mainly engaged in the research and development of interventional procedural medical devices. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The Company's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The Company operates its businesses primarily in domestic market.

  • Revenue in HKD (TTM)476.23m
  • Net income in HKD-423.76m
  • Incorporated2012
  • Employees1.04k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ClouDr Group Ltd3.98bn-348.77m968.61m1.52k--0.4488--0.2431-0.6447-0.64477.373.681.285.484.742,617,744.00-11.33---17.13--24.64---8.87--1.58-29.150.1314--23.51--80.87------
Ziyuanyuan Holdings Group Ltd537.58m15.72m1.22bn184.0072.003.3640.032.260.03930.03931.340.84330.81844.543.022,921,627.002.282.613.673.7124.69--2.786.131.752.340.31354.9653.4152.48-7.90-2.9897.56--
Beijing Airdoc Technology Co Ltd220.19m-143.08m1.31bn339.00--0.7885--5.95-1.38-1.382.1316.060.11912.262.84649,540.60-8.51---9.03--61.35---71.41--11.26--0.006--79.46--26.37------
Sisram Medical Ltd2.80bn245.89m1.41bn1.08k5.750.40063.840.50430.52480.52485.997.540.61471.804.392,597,016.005.635.946.706.8861.1057.669.1610.582.0013.960.086928.791.3618.48-21.597.6146.589.64
IVD Medical Holding Ltd3.33bn257.11m1.45bn803.004.680.33394.880.43390.19020.19022.472.670.67882.785.624,152,108.005.215.186.866.6721.7520.757.687.531.567.530.0923--12.3549.4913.4118.1519.77--
MicroTech Medical Hangzhou Co Ltd273.38m-134.96m1.50bn760.00--0.685--5.50-0.3171-0.31710.64225.230.11372.354.13359,707.80-5.62---5.85--49.13---49.37--21.22--0.00008--45.92---256.75------
Jenscare Scientific Co Ltd0.00-401.32m1.55bn376.00--1.17-----0.962-0.9620.003.190.00----0.00-27.49---28.61----------19.20--0.0347------15.38------
Gaush Meditech Ltd1.52bn187.33m1.66bn869.008.850.91356.171.091.271.2710.2612.260.50572.348.851,746,994.006.22--8.35--49.18--12.30--1.195.900.2814--12.16--149.63------
Peijia Medical Ltd476.23m-423.76m1.75bn1.04k--0.7139--3.68-0.624-0.6240.70113.610.14730.777337.52457,911.70-13.11-34.08-14.94-36.9073.7671.62-88.99-448.756.92--0.0886--75.86--3.75--106.68--
PW Medtech Group Ltd728.80m165.37m1.83bn1.24k11.080.41955.582.510.10560.10560.46552.790.13312.199.21585,854.604.047.234.918.0956.4258.1330.3785.3812.70--0.00024.1125.7516.7844.465.94-7.92--
MicroPort CardioFlow Medtech Corp362.97m-509.06m1.83bn592.00--0.7274--5.05-0.2154-0.21540.15361.040.12052.783.67613,123.30-16.91-17.37-18.11-22.962.06-1.67-140.25-180.829.91-11.560.0293--33.94---3.77---14.16--
Acotec Scientific Holdings Ltd511.55m15.64m1.96bn638.00120.541.4029.963.840.0520.0521.704.470.31360.72133.44801,808.800.9589--1.03--79.65--3.06--9.122.750.1529--19.80---79.35------
Venus MedTech HangZhou Inc530.47m-759.75m2.48bn865.00--0.7861--4.67-1.74-1.741.217.150.10140.94021.65613,264.20-15.04-13.20-17.41-14.9779.2179.51-148.37-152.831.86-8.780.2206--20.8933.6233.46--58.20--
Data as of Jul 26 2024. Currency figures normalised to Peijia Medical Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

23.45%Per cent of shares held by top holders
HolderShares% Held
FIL Investment Management (Hong Kong) Ltd.as of 15 Aug 202350.25m7.40%
Hillhouse Investment Management Ltd. (Hong Kong)as of 06 Dec 202340.74m6.00%
E Fund Management Co., Ltd.as of 31 Dec 202313.53m1.99%
UBS Asset Management (Hong Kong) Ltd.as of 28 Mar 202412.52m1.84%
Matthews International Capital Management LLCas of 05 Jul 202411.72m1.73%
The Vanguard Group, Inc.as of 30 Jun 202410.50m1.55%
FIL Investment Management (Singapore) Ltd.as of 15 Aug 20236.67m0.98%
Penghua Fund Management Co., Ltd.as of 31 Dec 20235.42m0.80%
Dimensional Fund Advisors LPas of 04 Jul 20244.02m0.59%
Bosera Asset Management Co., Ltd.as of 31 Dec 20233.96m0.58%
More ▼
Data from 31 Dec 2023 - 17 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.